Search Results 171-180 of 17359 for joseph murray

  1. Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet - Mayo Clinic

    Joseph Murray, M.D.. Contact information: Chadrick Hinson. (507) 538-6300. Contact UsHinson.Chadrick@mayo.edu. Open for enrollment. More information ...

  2. Role of Intestinal Inflammation in the Pathogenesis of Type 1 Diabetes - Mayo Clinic

    Joseph Murray, M.D.. Contact information: Carol Van Dyke CCRP. (507) 266-7842. Contact UsVanDyke.Carol@mayo.edu. Closed for enrollment. More information ...

  3. Faculty - Center for Individualized Medicine - Mayo Clinic Research

    D., R.N. · singh.komal@mayo.edu; Assistant Professor of Nursing; Publications · Skalski, Joseph H. M.D..

  4. Dr. Clifford Jack Archives - Mayo Clinic News Network

    the researchers say. “The majority of the Alzheimer's research field has really focused on amyloid over the last 25 years,” Dr. Murray says. “Initially, ...

  5. A Study of the Response to and Changes in Intestinal Permeability 4 hours after a Gluten Challenge in Subjects with Celiac Disease and Non Celiac Gluten Sensitivity - Mayo Clinic

    Joseph Murray, M.D.. Contact information: Carol Van Dyke CCRP. (507)266-7842. Contact UsVanDyke.Carol@mayo.edu. Closed for enrollment. More information ...

  6. Mucosal Interactions in Celiac Disease - Clinical Trials

    Joseph Murray, M.D.. Contact information: Carol Van Dyke CCRP. (507) 266-7842. Contact UsVanDyke.Carol@mayo.edu. Closed for enrollment. More information ...

  7. A Study to Evaluate the Safety, Tolerability, and Activity of Escalating Doses of AK002 in Patients with Eosinophilic Gastritis (EG) and/or Eosinophilic Gastroenteritis (EGE) - Mayo Clinic

    Joseph Murray, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  8. A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis - Mayo Clinic

    Joseph Murray, M.D.. Closed for enrollment. Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator. Benjamin Wright, M.D.. Closed for enrollment. More ...

  9. A Study to Evaluate the Safety and Effectiveness of AK002 in Patients with Active Eosinophilic Gastritis - Mayo Clinic

    Joseph Murray, M.D.. Closed for enrollment. Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator. Jennifer Horsley-Silva, M.D.. Closed for enrollment ...

  10. A Study of AK002 in Patients with Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis - Mayo Clinic

    Joseph Murray, M.D.. Closed for enrollment. Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator. Jennifer Horsley-Silva, M.D.. Closed for enrollment ...